Latest Stock Market News

Both margin and leverage look very similar to each other but there is a slight difference between the two. Leverage can be expressed in terms of ratio. In the above example, we got margin benefit and were asked to pay only Rs 5,000 for the underlying value of Rs 20,000 so in this case our leverage becomes 4:1.

JM Financial values the core banking business at 1.2x FY25E P/BV and arrives at its revised SoTP-based target price of Rs 675.

The total volume in DeFi is currently $5.31 billion, 10.86% of the total crypto market 24-hour volume. The volume of all stablecoins is now $42.41 billion, which is 86.72% of the total crypto market 24-hour volume.

“The CERC order is a good benchmark for us to go ahead and sign the supplementary PPA with the procurers including Gujarat and we are discussing with them and hopefully this should get signed within this quarter. We expect that this will become the new benchmark for how the Mundra tariff will be determined. ”

The high loan growth environment is partly driven by pent-up credit demand and normalisation of excess savings built up during the pandemic, as well as corporate borrowers migrating from the local bond markets towards banks, given the significant hardening in bond yields.

In cases where the custodial banks do not provide details of beneficial ownership, the regulator would deem those foreign funds ineligible and ask them to liquidate their holdings in the Indian market by March 2024, the source added.

The Relative Strength Index (RSI) is at 61.7. RSI below 30 is considered oversold and above 70 is considered overbought, Trendlyne data showed. MACD is above its center and signal line, this is a bullish indicator.

ITC on Friday reported a 21% YoY rise in net profit for the quarter ended December 2022 to Rs 5,031 crore. >> For more such web stories click on the ET icon below

Zydus Lifesciences, incorporated in the year 1995, is a Large Cap company (having a market cap of Rs 47583.72 Crore) operating in Pharmaceuticals sector.

"SBI’s core fundamentals continue to be on a strong footing and sustained solid earnings delivery should drive incremental re-rating for the stock in our view. While SBI may need to raise equity capital over the next 12-24 months (CET1 at 9.26%), stake sale in subsidiaries (SBI Funds, SBI General Insurance) remains another option to augment capital and may delay the eventual dilution.